Cisplatin and ifosfamide with various doses of vinorelbine (Navelbine) in advanced non-small cell lung cancer

被引：0
|
作者：
Souquet, PJ [1 ]
Fournel, P [1 ]
Bohas, CH [1 ]
Fortune, IC [1 ]
Chatte, G [1 ]
机构：
[1] CTR HOSP, DEPT PNEUMOL & THORAC ONCOL, ST ETIENNE, FRANCE
来源：
SEMINARS IN ONCOLOGY | 1996年 / 23卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：8 / 10
页数：3
相关论文
共 50 条
  • [1] Vinorelbine, ifosfamide and cisplatin in advanced non-small cell lung cancer
    Tan, EH
    Ang, PT
    Wee, J
    Fong, KW
    Leong, SS
    Khoo, KS
    ACTA ONCOLOGICA, 1999, 38 (05) : 619 - 622
  • [2] Cisplatin, ifosfamide and vinorelbine combination in advanced non-small cell lung cancer
    Baron, FJ
    Cueva, JF
    Vazquez, F
    Candamio, S
    Calvo, M
    Sanz, A
    Irigoyen, A
    Menendez, MD
    Huidobro, C
    Lopez, R
    ANNALS OF ONCOLOGY, 1998, 9 : 99 - 99
  • [3] Preliminary report on a phase I study of ifosfamide and vinorelbine (Navelbine) in advanced non-small cell lung cancer
    Masters, GA
    Hoffman, PC
    Drinkard, LC
    Watson, S
    Samuels, BL
    Golomb, HM
    Vokes, EE
    SEMINARS IN ONCOLOGY, 1996, 23 (02) : 11 - 18
  • [4] Vinorelbine, ifosfamide, and cisplatin combination as salvage chemotherapy in advanced non-small cell lung cancer
    Song, SY
    Kim, WS
    Kim, K
    Jung, CW
    Im, YH
    Kim, HJ
    Kang, WK
    Lee, HG
    Kwon, OJ
    Rhee, CH
    Park, CH
    Park, K
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2003, 33 (10) : 509 - 513
  • [5] Vinorelbine and alternating cisplatin and ifosfamide in the treatment of non-small cell lung cancer
    Barone, C
    Corsi, DC
    Pozzo, C
    Cassano, A
    Alvaro, G
    Colloca, G
    Landriscina, M
    Astone, A
    ONCOLOGY, 2000, 58 (01) : 25 - 30
  • [6] Update: Vinorelbine (Navelbine) in non-small cell lung cancer
    Crawford, J
    SEMINARS IN ONCOLOGY, 1996, 23 (02) : 2 - 7
  • [7] Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer: CALGB 9532
    Perry, MC
    Ihde, DC
    Herndon, JE
    Grossbard, ML
    Grethein, SJ
    Atkins, JN
    Vokes, EE
    Green, MR
    LUNG CANCER, 2000, 28 (01) : 63 - 68
  • [8] Cisplatin, vindesine, mitomycin (MVP) vs cisplatin, ifosfamide, navelbine (PIN) vs carboplatin, navelbine (CAN) in advanced non-small cell lung cancer (NSCLC)
    Baldini, E
    Portalone, L
    DeMarinis, F
    Barbera, S
    Ardizzoni, A
    Pennucci, MC
    Raimondi, M
    Conte, PF
    Salvati, F
    Cafferata, MA
    Soresi, E
    Porcile, GF
    Testore, F
    Rimoldi, R
    Bandera, M
    DiRosa, T
    Rinaldi, M
    Lionetto, R
    Rosso, R
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1059 - 1059
  • [9] Navelbine (NVB) and fractionated doses of cisplatin (CDDP) for the treatment of advanced non-small cell lung cancer (NSCLC)
    Altino, J
    Anelli, A
    Rodrigues, J
    Malzyner, A
    Delgado, RGL
    Murad, A
    Caponero
    Yamaguchi, N
    Gampel, O
    Danel, P
    Martinez, A
    Penna, M
    Delgado, FM
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1091 - 1091
  • [10] Gemcitabin, cisplatin (GP) versus vinorelbine, ifosfamide, cisplatin (NIP) in locally advanced non-small cell lung cancer (NSCLC)
    Certíková, G
    Eliasová, B
    Pesek, M
    LUNG CANCER: CURRENT TOPICS, 2001, : 103 - 108
12345